SEARCH

Current Edition

FDA

Former Immunomedics executive charged with insider trading around trial data

Early in the spring of 2020, Immunomedics was waiting for the Food and Drug Administration to decide on accelerated approval of the company’s breast cancer …

Continue Reading →